EVITRADE Health Systems Corp. completed the Spin-Off of Eviana Health Corporation
The transaction is subject to regulatory and judicial approvals, C&C Cosmeceuticals shareholder approval and approval by EVITRADE Health Systems shareholders. As of February 6, 2017, the transaction was unanimously approved by EVITRADE Health Systems board. As of March 3, 2017, the transaction received unanimous approval from the shareholders of EVITRADE. As on March 17, 2017, the transaction received approval from the Supreme Court of British Columbia and the record date for the first subsidiary company holding the TULIP(TM) Intellectual Property to be spun off is decided as March 20, 2017. The transaction is expected to close on March 9, 2017. The record date for the distribution to shareholders will be April 4, 2017. As on April 21, 2017, the ex-distribution date is April 24, 2017, and the share dividend record date for C&C Cosmeceuticals has been amended to be April 26, 2017. Haywood Securities Inc. acted as financial advisor for EVITRADE Health Systems Corp.
EVITRADE Health Systems Corp. (CNSX:AID) completed the spin-off of C&C Cosmeceuticals Corp. on May 24, 2017.